ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

Avon Awards $30M To 13 Organizations

September 27, 2002

Letter: ORI And Plotkin Should Release Report

June 23, 1995

NCCN Launches Outcomes Improvement Program

August 12, 2011

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014